中文 | English
Return
Total: 33 , 1/4
Show Home Prev Next End page: GO
Author:(Mu-Zi LIU)

1.Application of intra-articular graft length measurement in total anterior cruciate ligament reconstruction

Shi-Guo GONG ; Rong-Hui XIE ; Jian-Yang WANG ; Mu-Zi LIU

China Journal of Orthopaedics and Traumatology 2024;37(7):655-663

2.RBM46 is essential for gametogenesis and functions in post-transcriptional roles affecting meiotic cohesin subunits.

Yue LV ; Gang LU ; Yuling CAI ; Ruibao SU ; Liang LIANG ; Xin WANG ; Wenyu MU ; Xiuqing HE ; Tao HUANG ; Jinlong MA ; Yueran ZHAO ; Zi-Jiang CHEN ; Yuanchao XUE ; Hongbin LIU ; Wai-Yee CHAN

Protein & Cell 2023;14(1):51-63

3.Clinical value of the MeltPro MTB assays in detection of drug-resistant tuberculosis in paraffin-embedded tissues.

Jia Lu CHE ; Zi Chen LIU ; Kun LI ; Wei Li DU ; Dan ZHAO ; Jing MU ; Yu Jie DONG ; Nan Ying CHE

Chinese Journal of Pathology 2023;52(5):466-471

4.Effect of a novel phosphodiesterase 5 inhibitor, CPD1, on renal interstitial fibrosis after unilateral renal ischemia-reperfusion injury.

Ao-Lu LIU ; Zhuang LI ; Mei-Zhi LU ; Hao-Heng QIU ; Zhong-Lian XIE ; Xiao-Qing LIU ; Allan Zi-Jian ZHAO ; Yun-Ping MU ; Fang-Hong LI

Acta Physiologica Sinica 2023;75(1):1-9

6. Effect of menthol, a transient receptor potential melastatin-8 channel activator, on pulmonary arterial hypertensive rats

Hao-Heng GTU ; Zhuang LI ; Jian-Qin YANG ; Wen-Bin FENG ; Xiao-Qing LIU ; Zi-Jian ZHAO ; Yun-Ping MU ; Fang-Hong LI ; Bin LI

Chinese Pharmacological Bulletin 2023;39(4):700-706

7. Effect of a novel phosphodiesterase type 5 inhibitor,CPD1,on unilateral renal interstitial fibrosis caused by ureteric obstruction in mice

Ao-Lu LIU ; Wen-Bin FENG ; Bin LI ; Xin-Hui CHEN ; Si-Rong LI ; Zi-Jian ZHAO ; Yun-Ping MU ; Fang-Hong LI ; Qian REN

Chinese Pharmacological Bulletin 2023;39(1):147-152

8.Application characteristics and modern research progress of "bone-approaching" acupuncture.

De-Hui ZOU ; Kai-Xin FENG ; Hong-Wen LIANG ; Xu-Hao TANG ; Shan ZHAO ; Zi-Jian QIU ; Peng-Yong BAI ; Jia-Mu LIU ; Tong LIU

Chinese Acupuncture & Moxibustion 2023;43(9):1094-1098

9.Co-delivery of Tim-3 mAb and sorafenib enhanced chemoimmunotherapy for hepatocellular carcinoma using "responsive shell-peeling" mesoporous silica nanoparticles

Sheng-jun MU ; Xiao SANG ; Wei-wei MU ; Tian-qi WANG ; Rui YANG ; Zi-peng ZHANG ; Yong-jun LIU ; Na ZHANG

Acta Pharmaceutica Sinica 2022;57(1):200-210

10. Effect of FKBP38 expression on occurrence and development of nonalcoholic fatty liver disease in mice

Min-Yi TANG ; Shuai WANG ; Chao-Feng XING ; Ao-Lu LIU ; Zi-Jian ZHAO ; Yun-Ping MU ; Li-Na WANG ; Fang-Hong LI

Chinese Pharmacological Bulletin 2022;38(4):518-524

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 33 , 1/4 Show Home Prev Next End page: GO